Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978564415> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W1978564415 endingPage "44" @default.
- W1978564415 startingPage "44" @default.
- W1978564415 abstract "Sunitinib is a potent oral tyrosine kinase inhibitor of VEGFRs, KIT, and PDGFRs. In a single arm phase II trial, sunitinib has demonstrated its potential activity in refractory thymic carcinoma (TC) and thymoma (T). Taking advantage of the French RYTHMIC network prospective database, we investigated the off-label efficacy of sunitinib in previously-treated thymic epithelial tumors (TETs) patients not included in a clinical trial.RYTHMIC database started in 2012, and prospectively collects clinical, imaging, treatment, and follow-up data of all patients diagnosed with TET, for whom management is discussed at a national multidisciplinary tumor board. All patients who received sunitinib were selected for this analysis.28 patients from 7 institutions were identified, including 20 TC and 8 T; 32% of patients were females, and median age was 50 years. Fifteen patients (54%) received sunitinib as ≥4th line treatment. The initial daily dose of sunitinib was 50 mg in 11 patients, 37.5 mg in 16 patients and 25 mg in 1 patient. Sunitinib adverse events were all manageable and tolerable; 8 patients had to stop sunitinib due to toxicity after a median duration of treatment of 2.7 months. In the overall population, disease control rate was of 63% (86% for T, and 55% for TC); overall response rate was 22% (29% for T, and 20% for TC). Median PFS in the whole population was 3.7 months (5.4 months for T, and 3.3 months for TC, p = 0.097). The median overall survival in the whole population was 15.4 months: survival was not reached for T, and was 12.3 months for TC patients (p = 0.043).Sunitinib is an active treatment in TETs irrespective of histological subtype, supporting the use of tyrosine kinase inhibitors with anti-angiogenic activity as alternative treatment options in refractory disease." @default.
- W1978564415 created "2016-06-24" @default.
- W1978564415 creator A5010204610 @default.
- W1978564415 creator A5019537321 @default.
- W1978564415 creator A5027572658 @default.
- W1978564415 creator A5031067983 @default.
- W1978564415 creator A5037655243 @default.
- W1978564415 creator A5047061431 @default.
- W1978564415 creator A5047860622 @default.
- W1978564415 creator A5048710926 @default.
- W1978564415 creator A5091030888 @default.
- W1978564415 date "2004-09-01" @default.
- W1978564415 modified "2023-09-26" @default.
- W1978564415 title "135 A clinical phase I dose escalation, pharmacokinetic (PK) and pharmacodynamic (PD) study of BIBF 1120 in advanced cancer patients" @default.
- W1978564415 doi "https://doi.org/10.1016/s1359-6349(04)80144-7" @default.
- W1978564415 hasPublicationYear "2004" @default.
- W1978564415 type Work @default.
- W1978564415 sameAs 1978564415 @default.
- W1978564415 citedByCount "2" @default.
- W1978564415 crossrefType "journal-article" @default.
- W1978564415 hasAuthorship W1978564415A5010204610 @default.
- W1978564415 hasAuthorship W1978564415A5019537321 @default.
- W1978564415 hasAuthorship W1978564415A5027572658 @default.
- W1978564415 hasAuthorship W1978564415A5031067983 @default.
- W1978564415 hasAuthorship W1978564415A5037655243 @default.
- W1978564415 hasAuthorship W1978564415A5047061431 @default.
- W1978564415 hasAuthorship W1978564415A5047860622 @default.
- W1978564415 hasAuthorship W1978564415A5048710926 @default.
- W1978564415 hasAuthorship W1978564415A5091030888 @default.
- W1978564415 hasConcept C121332964 @default.
- W1978564415 hasConcept C121608353 @default.
- W1978564415 hasConcept C126322002 @default.
- W1978564415 hasConcept C126894567 @default.
- W1978564415 hasConcept C141071460 @default.
- W1978564415 hasConcept C142424586 @default.
- W1978564415 hasConcept C143998085 @default.
- W1978564415 hasConcept C197934379 @default.
- W1978564415 hasConcept C2778820342 @default.
- W1978564415 hasConcept C2779490328 @default.
- W1978564415 hasConcept C2908647359 @default.
- W1978564415 hasConcept C31760486 @default.
- W1978564415 hasConcept C535046627 @default.
- W1978564415 hasConcept C71924100 @default.
- W1978564415 hasConcept C87355193 @default.
- W1978564415 hasConcept C90924648 @default.
- W1978564415 hasConcept C99454951 @default.
- W1978564415 hasConceptScore W1978564415C121332964 @default.
- W1978564415 hasConceptScore W1978564415C121608353 @default.
- W1978564415 hasConceptScore W1978564415C126322002 @default.
- W1978564415 hasConceptScore W1978564415C126894567 @default.
- W1978564415 hasConceptScore W1978564415C141071460 @default.
- W1978564415 hasConceptScore W1978564415C142424586 @default.
- W1978564415 hasConceptScore W1978564415C143998085 @default.
- W1978564415 hasConceptScore W1978564415C197934379 @default.
- W1978564415 hasConceptScore W1978564415C2778820342 @default.
- W1978564415 hasConceptScore W1978564415C2779490328 @default.
- W1978564415 hasConceptScore W1978564415C2908647359 @default.
- W1978564415 hasConceptScore W1978564415C31760486 @default.
- W1978564415 hasConceptScore W1978564415C535046627 @default.
- W1978564415 hasConceptScore W1978564415C71924100 @default.
- W1978564415 hasConceptScore W1978564415C87355193 @default.
- W1978564415 hasConceptScore W1978564415C90924648 @default.
- W1978564415 hasConceptScore W1978564415C99454951 @default.
- W1978564415 hasIssue "8" @default.
- W1978564415 hasLocation W19785644151 @default.
- W1978564415 hasOpenAccess W1978564415 @default.
- W1978564415 hasPrimaryLocation W19785644151 @default.
- W1978564415 hasRelatedWork W134447636 @default.
- W1978564415 hasRelatedWork W1981278563 @default.
- W1978564415 hasRelatedWork W2096056144 @default.
- W1978564415 hasRelatedWork W2136140812 @default.
- W1978564415 hasRelatedWork W2397703782 @default.
- W1978564415 hasRelatedWork W2528057197 @default.
- W1978564415 hasRelatedWork W2603291805 @default.
- W1978564415 hasRelatedWork W2922116982 @default.
- W1978564415 hasRelatedWork W3183900543 @default.
- W1978564415 hasRelatedWork W4313210082 @default.
- W1978564415 hasVolume "2" @default.
- W1978564415 isParatext "false" @default.
- W1978564415 isRetracted "false" @default.
- W1978564415 magId "1978564415" @default.
- W1978564415 workType "article" @default.